Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain

Max Hodak's startup, Science Corp., is advancing its biohybrid brain-computer interface by preparing for its first human trials. Dr. Murat Günel, chair of Neurosurgery at Yale Medical School, has joined as a scientific advisor to oversee the surgical implantation of the company's sensor into a patient's brain. This innovative sensor aims to integrate lab-grown neurons with electronics, offering a more organic approach than traditional electrode-based methods, which Hodak believes cause brain damage. Science Corp.'s most advanced product, PRIMA, is designed to restore vision for those with macular degeneration, and the company has secured significant funding. While Neuralink and others have made progress in detecting brain activity for controlling devices, Hodak's vision extends to human enhancement. The biohybrid sensor, developed by Alan Mardinly, will be implanted under the skull and rest on the brain's surface, avoiding direct brain tissue insertion. The company plans to test the sensor without embedded neurons first, potentially in patients already undergoing significant brain surgery. If successful, the device could treat various neurological conditions, including Parkinson's disease, by potentially halting disease progression.

(Source：TechCrunch)